
Saftak 125mg Injection
Marketer
Safetech Formulation
Salt Composition
Ceftriaxone (125mg)
Overview Saftak 125mg Injection
Ceftazidime 125mg injection, a cephalosporin antibiotic, combats various bacterial infections. Its applications span diverse sites: central nervous system (meningitis), respiratory tract (pneumonia), ears, urinary system, skin and soft tissues, musculoskeletal system, bloodstream, and cardiac structures. Prophylactically, it prevents surgical site infections. Administered intravenously (drip) or intramuscularly by a healthcare professional, dosage is determined individually. Regular, evenly spaced doses, as directed, are crucial; completing the prescribed course is vital to prevent relapse. Common side effects – diarrhea, skin rash, altered liver function test results, and blood cell abnormalities (eosinophilia, leukopenia, thrombocytopenia) – are usually mild, but warrant reporting. Injection site reactions (erythema, pain) may occur temporarily. Prior to use, disclose any antibiotic allergies, hepatic or renal impairment, and all other medications to your doctor, as interactions are possible.
Primary Ingredients of Saftak 125mg Injection
There is no text provided to rephrase.
Uses of Saftak 125mg Injection
Combating bacterial infections
Major Benefits of Saftak 125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Saftak 125mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Saftak 125mg Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
How Saftak 125mg Injection works:
Ceftazidime 125mg injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Saftak 125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Saftak, at a 125mg dose, poses minimal to no documented risk to the fetus during gestation, based on the majority of research findings.
Breast feedingCAUTION
Administering Saftak 125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Saftak 125mg Injection can lead to drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
Ceftazidime 125mg Injection poses no known risk requiring dose modification in individuals with renal impairment. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advised.
LiverCAUTION
For individuals with severely impaired liver function, Saftak 125mg Injection requires careful administration and potential dosage modification. Patients with mild to moderate liver impairment do not typically require Saftak 125mg Injection dose adjustments; however, medical consultation is advised in all cases.
What if you forget to take Saftak 125mg Injection :
Omitting a scheduled dose of Saftak 125mg Injection warrants contacting your physician.
Facts to Know About Saftak 125mg Injection
| Label | Value |
|---|---|
| Chemical Type | Advanced Cephalosporins (Third and Fourth Generation) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
